Buter, J <br/><br/>
Phase I/II study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancer.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  1993 
 - 2108-13 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Standard No.: </label>10.1016/0959-8049(93)90044-g  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Carcinoma, Renal Cell--drug therapy<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Injections, Subcutaneous<br/>Interleukin-2--administration & dosage<br/>Kidney Neoplasms--pathology<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Muromonab-CD3--administration & dosage